(Watch the video HERE)



In this interview, Sara Barrington CEO of Verici Dx (VRCI ) takes Vox through today's excellent validation study results wrt its next generation (pre graft) kidney transplant blood test, Clarava. Alongside how the diagnostic will be commercialised & what its means for doctors, hospitals & patients.